ストックスクリーナーアプリを入手
2.05
1.91%
-0.04
前日終値:
$2.09
開ける：
$2.1101
24時間の取引高:
46,197
Relative Volume:
0.26
時価総額：
$3.40M
収益：
$8.97M
当期純損益:
$-15.21M
株価収益率:
-0.0176
EPS:
-116.51
ネットキャッシュフロー:
$-10.84M
1週間 パフォーマンス:
-24.07%
1か月 パフォーマンス:
-35.94%
6か月 パフォーマンス:
+127.78%
1年 パフォーマンス:
+65.32%
1日の値動き範囲:
$2.03
$2.12
1週間の範囲:
$2.03
$2.70
52週間の値動き範囲:
$0.19
$25.95
Nuwellis Inc Stock (NUWE) Company Profile
NUWE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
2.05 | 1.89M | 8.97M | -15.21M | -10.84M | -116.51 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-29 | 開始されました | ROTH MKM | Buy |
Nuwellis Inc (NUWE) 最新ニュース
Nuwellis (NUWE) Gets a Hold from Maxim Group - The Globe and Mail
Is Nuwellis Inc. stock a buy on dips2025 Investor Takeaways & Expert Verified Movement Alerts - newser.com
Will Nuwellis Inc. stock benefit from commodity pricesRate Hike & Low Risk Investment Opportunities - newser.com
Will Nuwellis Inc. stock benefit from green energy trendsTrade Exit Report & Verified Short-Term Trading Plans - newser.com
Comparing Nuwellis Inc. in custom built stock radarsQuarterly Profit Summary & Long-Term Capital Growth Ideas - newser.com
What candlestick patterns are forming on Nuwellis Inc.Trade Risk Report & AI Based Buy and Sell Signals - newser.com
Developing predictive dashboards with Nuwellis Inc. dataPortfolio Performance Report & Long-Term Capital Growth Strategies - newser.com
Nuwellis receives notice of allowance for U.S. patent on Vivian system - MSN
Can swing trading help recover from Nuwellis Inc. lossesQuarterly Portfolio Review & Breakout Confirmation Trade Signals - newser.com
Nuwellis Reports Q3 2025 Results and Strategic Advances - TipRanks
Earnings call transcript: Nuwellis Q3 2025 reveals revenue decline, stock dips - Investing.com Nigeria
Nuwellis Inc (NUWE) Q3 2025 Earnings Call Highlights: Strong Seq - GuruFocus
Nuwellis Inc (NUWE) Q3 2025 Earnings Call Highlights: Strong Sequential Growth Amid Revenue ... - Yahoo Finance
Nuwellis Q3 2025 Earnings Call Transcript - MarketBeat
Nuwellis Q3 Earnings Preview - MSN
Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum - The Manila Times
Medical tech firm Nuwellis Q3 revenue down 6% yr/yr - MarketScreener
Nuwellis, Inc. Reports Third Quarter 2025 Financial Results and Strategic Milestones - Quiver Quantitative
Nuwellis (NASDAQ: NUWE) posts $2.2M Q3 revenue; pro-forma up 7% YoY, on U.S. strength - Stock Titan
How rising interest rates impact Nuwellis Inc. stockQuarterly Market Summary & Verified Swing Trading Watchlist - newser.com
Nuwellis receives patent for safety technology in pediatric blood filtration By Investing.com - Investing.com Nigeria
Nuwellis (NUWE) Secures Patent for Innovative Blood Filtration S - GuruFocus
Nuwellis Inc. Secures Patent for Advanced Safety Mechanisms in Pediatric Blood Filtration Systems - Quiver Quantitative
Nuwellis receives patent for safety technology in pediatric blood filtration - Investing.com
Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology - The Manila Times
Nuwellis (Nasdaq: NUWE) receives USPTO notice for Vivian Pediatric CRRT clamp safety tech - Stock Titan
Nuwellis Inc (NUWE) 財務データ
収益
当期純利益
現金流量
EPS
5.84%
大文字化:
|
ボリューム (24 時間):